|
DE4302485A1
(de)
*
|
1993-01-29 |
1994-08-04 |
Merck Patent Gmbh |
Piperazinderivate
|
|
FR2768728B1
(fr)
|
1997-09-19 |
1999-12-03 |
Rhodia Chimie Sa |
Procede d'acylation d'un compose aromatique
|
|
FR2768729A1
(fr)
|
1997-09-19 |
1999-03-26 |
Rhodia Chimie Sa |
Procede d'acylation d'un compose aromatique et complexes catalytiques
|
|
US7629360B2
(en)
|
1999-05-07 |
2009-12-08 |
Celgene Corporation |
Methods for the treatment of cachexia and graft v. host disease
|
|
US8470829B2
(en)
*
|
2004-09-09 |
2013-06-25 |
Chugai Seiyaku Kabushiki Kaisha |
Imidazolidine derivative and use thereof
|
|
WO2007073432A2
(en)
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
US20080064876A1
(en)
*
|
2006-05-16 |
2008-03-13 |
Muller George W |
Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
RU2434851C1
(ru)
|
2010-07-22 |
2011-11-27 |
Александр Васильевич Иващенко |
Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
|
|
US8765978B2
(en)
|
2010-12-16 |
2014-07-01 |
Transitions Optical, Inc. |
Method of making indeno-fused naphthol materials
|
|
EP2683694B1
(en)
*
|
2011-03-10 |
2016-04-27 |
Suzhou Kintor Pharmaceuticals, Inc. |
Androgen receptor antagonists and uses thereof
|
|
US20140112922A1
(en)
|
2011-03-28 |
2014-04-24 |
Cornell University |
Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes
|
|
KR102668696B1
(ko)
|
2012-01-12 |
2024-05-29 |
예일 유니버시티 |
E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
|
|
WO2014036897A1
(zh)
*
|
2012-09-04 |
2014-03-13 |
上海恒瑞医药有限公司 |
咪唑啉类衍生物、其制备方法及其在医药上的应用
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
RU2683788C2
(ru)
|
2013-01-31 |
2019-04-02 |
Вертекс Фармасьютикалз Инкорпорейтед |
Амиды хинолина и хиназолина, полезные в качестве модуляторов натриевых каналов
|
|
RU2738833C9
(ru)
|
2014-04-14 |
2022-02-28 |
Арвинас, Оперэйшнз, Инк. |
Имидные модуляторы протеолиза и способы их применения
|
|
US20160058872A1
(en)
|
2014-04-14 |
2016-03-03 |
Arvinas, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
RU2557235C1
(ru)
|
2014-07-08 |
2015-07-20 |
Александр Васильевич Иващенко |
Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты
|
|
WO2016105518A1
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
JP6817962B2
(ja)
|
2015-01-20 |
2021-01-20 |
アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． |
ターゲティングされたアンドロゲン受容体分解のための化合物および方法
|
|
EP3270917A4
(en)
|
2015-03-18 |
2018-08-08 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
GB201506871D0
(en)
|
2015-04-22 |
2015-06-03 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
EP3319944A4
(en)
|
2015-07-10 |
2019-04-24 |
Arvinas, Inc. |
MDM2-BASED MODULATORS OF PROTEOLYSIS AND RELATED USE METHODS
|
|
US10772962B2
(en)
|
2015-08-19 |
2020-09-15 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
|
CN110167556A
(zh)
|
2016-07-08 |
2019-08-23 |
詹森药业有限公司 |
用于治疗癌症的硫代乙内酰脲雄性激素受体拮抗剂
|
|
TWI739888B
(zh)
|
2016-10-07 |
2021-09-21 |
美商陶氏農業科學公司 |
農藥組合物及方法
|
|
CN110506039A
(zh)
|
2016-10-11 |
2019-11-26 |
阿尔维纳斯股份有限公司 |
用于雄激素受体靶向降解的化合物和方法
|
|
US10925868B2
(en)
|
2016-11-10 |
2021-02-23 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
|
|
WO2018098280A1
(en)
|
2016-11-22 |
2018-05-31 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
|
|
AU2017378943B2
(en)
|
2016-12-19 |
2020-06-18 |
Abbisko Therapeutics Co., Ltd. |
FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof
|
|
IL312367A
(en)
|
2017-01-31 |
2024-06-01 |
Arvinas Operations Inc |
Cereblon ligands and bifunctional compounds comprising the same
|
|
CN110769822A
(zh)
|
2017-06-20 |
2020-02-07 |
C4医药公司 |
用于蛋白降解的n/o-连接的降解决定子和降解决定子体
|
|
CN109422725A
(zh)
|
2017-09-04 |
2019-03-05 |
北京美倍他药物研究有限公司 |
前列腺癌治疗药物
|
|
ES2959954T3
(es)
|
2017-11-28 |
2024-02-29 |
Aarti Pharmalabs Ltd |
Proceso para la preparación de enzalutamida utilizando un nuevo intermedio
|
|
EP3720281A4
(en)
|
2017-12-05 |
2021-05-26 |
Dow Agrosciences LLC |
PESTICIDE COMPOSITIONS AND PROCEDURES
|
|
CN114835729B
(zh)
|
2018-05-30 |
2024-05-31 |
江苏豪森药业集团有限公司 |
含三并环类衍生物抑制剂、其制备方法和应用
|
|
CN109651256A
(zh)
|
2018-11-20 |
2019-04-19 |
上海健康医学院 |
一种式（viii）的恩杂鲁胺的制备方法
|
|
CN113453681B
(zh)
|
2018-12-19 |
2024-10-11 |
细胞基因公司 |
经取代的3-((3-氨基苯基)氨基)哌啶-2，6-二酮化合物、其组合物及使用它们的治疗方法
|